CRISPR Therapeutics AG (NASDAQ:CRSP)

78.99
Delayed Data
As of Nov 26
 -1.93 / -2.39%
Today’s Change
77.42
Today|||52-Week Range
220.20
-48.41%
Year-to-Date

Stock Price Forecast

The 19 analysts offering 12-month price forecasts for CRISPR Therapeutics AG have a median target of 160.00, with a high estimate of 220.00 and a low estimate of 100.00. The median estimate represents a +102.56% increase from the last price of 78.99.

Analyst Recommendations

The current consensus among 22 polled investment analysts is to Buy stock in CRISPR Therapeutics AG. This rating has held steady since November, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$1.69
Sales
$2.4M
Reporting Date
Mar 11

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -1.35%
 
 
 
 
 
 
Growthannually 192.15%
 
 
 
 
 
 

Sales

Growthquarterly 190.86%
 
 
 
 
 
 
Growthannually 125,680.34%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.